Pancreatic Cancer Research

ResearcherWuhan Union HospitalNo recent work listed

Jing Cui

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7994-2890; OpenAlex author ID A5101599546. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper

Papers 3

  1. Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CC… Co-author DOI 10.3390/cells11233893↗
  2. Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling. Co-author DOI 10.1186/s10020-021-00300-8↗
  3. Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer. Co-author DOI 10.1186/s13046-021-01894-x↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Peng · 2 shared papers, 2021–2022 · strength 0.32
  2. Yao Guo · 2 shared papers, 2021 · strength 0.32
  3. Heshui Wu · 2 shared papers, 2021 · strength 0.32
  4. Taoyu Chen · 1 shared paper, 2022 · strength 0.17
  5. Shanmiao Gou · 1 shared paper, 2022 · strength 0.17
  6. Yao Guo · 1 shared paper, 2022 · strength 0.17
  7. Tao Peng · 1 shared paper, 2021 · strength 0.17
  8. Xiaoxiao Zhou · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.